- $3.98bn
- $3.76bn
- $582.01m
- 97
- 26
- 89
- 82
Annual cashflow statement for Exponent, fiscal year end - January 2nd, USD millions except per share, conversion factor applied.
2021 January 1st | 2022 December 30th | 2023 December 29th | 2025 January 3rd | 2026 January 2nd | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 53 W | — |
| Source: | 10-K | 10-K | 10-K | 10-K | |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 82.6 | 102 | 100 | 109 | — |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 19 | 23.4 | 23.6 | 27.7 | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.44 | -31.7 | -5.57 | 1.46 | — |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 103 | 93.8 | 127 | 145 | — |
| Capital Expenditures | -4.99 | -12 | -16.4 | -6.94 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 10 | 0 | 0 | — | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 5.02 | -12 | -16.4 | -6.94 | — |
| Financing Cash Flow Items | -15.3 | -12.9 | -9.94 | -6.92 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -88.4 | -216 | -86 | -65.1 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 21.1 | -136 | 25.7 | 71.8 | — |